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Purpose: To evaluate the anti-enterobacterial potential of nine ethnobotanically selected plants 
traditionally used in different parts of India for the treatment of gastrointestinal disorders such as 
cholera, diarrhea or dysentery.  
Methods: The methanol extracts of these plants were screened for antibacterial activity against 11 
strains of enteropathogenic bacteria, including multi-drug resistant Vibrio cholerae (serotypes O1, O139, 
and non-O1, non-O139), using broth microdilution method. Ampicillin was used as a positive reference 
standard to determine the sensitivity of the strains. Phytochemical screening was carried out for 
phenolics and flavonoids. 
Results: All of these plants had bactericidal activity against at least one of the test microorganisms with 
minimum inhibitory concentration (MIC) ranging from 0.125 to 32 mg/ml and minimum bactericidal 
concentration (MBC) ranging from 0.25 to 32 mg/ml. Among these, Terminalia chebula Retz. 
(Combretaceae) and Syzygium cumini (L.) Skeels (Myrtaceae) showed the most promising broad 
spectrum antibacterial properties, inhibiting all of the strains tested, especially Vibrio cholerae, 
Aeromonas hydrophila and Bacillus  subtilis, with MBC ranging from 0.25 to 4 mg/ml. Phenolics and 
flavonoids were found to be present in the extracts. 
Conclusion: The findings provide support for the use of this plant in traditional medicine for treatment 
of diarrheoa, especially cholera. 
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INTRODUCTION 
 
Morbidity and mortality due to diarrheoa 
continues to be a major problem in many 
developing countries, including India and 
Bangladesh, especially amongst children. 
Infections due to a variety of bacterial 
etiologic agents, such as pathogenic 
Escherichia coli, Vibrio cholerae, Areomonas 
spp., Shigella spp., Salmonella spp., 
Pseudomonas spp., Klebsiella spp., 
Campylobacter spp., and Staphylococcus 
aureus are most common. However, 
antibiotic resistance is a major clinical 
problem in treating infections caused by 
these microorganisms. Many readily available 
plants in India are used in traditional folklore 
medicine for the treatment of gastrointestinal 
disorders such as cholera, diarrhea and 
dysentery
1-7
. However, several of them have 
not been investigated from a pharmacological 
point of view to demonstrate their 
antibacterial properties, which could support 
their use as anticholera or antidiarrheal 
remedies in traditional medicine.  
The objective of the present study was to 
evaluate the antibacterial activities of the 
extracts of some plants used in Indian 
traditional healthcare system, against a group 
of pathogenic bacteria. These plants are 
used by the indigenous people in different 
parts of India for the treatment of infectious 
diseases such as cholera, diarrhea, 







We ethnobotanically selected nine Indian 
medicinal plants [Albizia lebbeck (L.) Benth. 
(Mimosaceae), Terminalia chebula Retz. 
(Combretaceae), Syzygium cumini (L.) 
Skeels (Myrtaceae), Solanum nigrum L. 
(Solanaceae), Picrorhiza kurrooa Royle ex 
Benth. (Scrophulariaceae), Butea 
monosperma (Lam.) Taub. (Papilionaceae), 
Saraca indica auct.non L. (Leguminosae), 
Aegle marmelos (L.) Correa ex Roxb. 
(Rutaceae), and Withania somnifera (L.) 
Dunal (Solanaceae)] for antimicrobial 
screening in the present study. The plants 
were collected by the authors from the local 
area (West Bengal) and another region 
(Uttaranchal) in India. The botanical 
identification of the plant samples was carried 
out by Drs ABD. Selvan and Madhusudan 
Mandal of Botanical Survey of India (BSI), 
Central National Herbarium, Botanic Garden, 
Howrah, India. The voucher specimens are 
conserved at Central National Herbarium, 
BSI, Botanic Garden, Howrah, India. Plant 
species, local names, parts used, and the 
voucher specimen numbers are listed in 
Table 1. 
 
Other materials and reagents 
 
Among the clinical strains of V. cholerae used 
in this study, strains NB2 and SG24 belonged 
to O1 and O139 serotypes, respectively. The 
other strains used in this study were V. 
cholerae non-O1, non-O139 (strains PC4 and 
PC65); Klebsiella pneumoniae strain PC36; 
A. hydrophila strain PC16; Escherichia coli 
strain PC80 (Enterotoxigenic Escherichia coli, 
ETEC) and E. coli strain VT3 
(Enterohaemorrhagic E. coli, EHEC); 
Pseudomonas aeruginosa ATCC 15442; and 
Bacillus subtilis ATCC 6623. Antimicrobial 
susceptibility testing was performed by the 
disc diffusion method
8
 with commercially 
available disks (HiMedia, Mumbai, India) of  
ampicillin (A) (10 µg); chloramphenicol (C)(30 
µg); co-trimoxazole (Co) (25 µg); 
ciprofloxacin (Cf)(5 µg); furazolidone (Fz) 
(100 µg); gentamicin (G)(10 µg); neomycin 
(N) (30 µg); nalidixic acid (Na) (30 µg); 
norfloxacin (Nx) (10 µg); streptomycin (S) (10 
µg); tetracycline (T) (30 µg). 
 
Preparation of extracts 
 
Plant extracts were prepared by macerating 
the air-dried plant part (500 g) with 2500 ml of 
methanol in a Soxhlet apparatus for 18 h
9
. 
The extract was then filtered through 
Whatman no. 42 filter paper and concentra- 
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Table 1: List of plant species with relevant information  
 
 
ted in a rotary vacuum evaporator (Eyela, 
Japan). The concentrated extract (30 ml) was 
freeze-dried at 0.05 mbar pressure and – 
60°C for 4 h in a LSL Secfroid lyophilizer 
(Lyolab BII, Aclens-Lausanne, Switzerland). 
The dried material was stored at - 20°C 
pending further use. The yield of each extract 
is shown in Table 1. Test samples were 
prepared by re-suspending the lyophilized 




Isolates were considered susceptible, less 
susceptible, or resistant to a particular 
antimicrobial agent on the basis of the 
diameters of the inhibitory zones that 
matched the criteria of the manufacturer's 
interpretation table, which followed the 
recommendations of the National Committee 
for Clinical Laboratory Standards
10
. The 
American Type Culture Collection (ATCC) 
strains, Escherichia coli ATCC 25922 and 
Staphylococcus aureus ATCC 25923, were 
used for quality control.  
 
Minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) 
were assessed using the broth microdilution 
method
11
. An inoculum of the microorganism 
was prepared from 24 h cultures grown in 
Mueller-Hinton broth (MHB) (HiMedia) and
 
suspension was adjusted with a turbidity 
equivalent to that of a 0.5 McFarland
 
standard. The suspension was further diluted 
1:10
 
in sterile MHB to obtain a final inoculum 
of 5 × 10
5
 CFU/ml. The 96-well round bottom 
sterile plates were prepared by dispensing 
180 µl of the inoculated broth into each well. 
A 20 µl aliquot of the plant extract was 
added. The concentrations of plant extract 
tested were 0.05, 0.125, 0.25, 0.4, 0.5, 0.75, 
1, 1.25, 1.5, 1.75, 2, 2.5, 3, 3.5, 4, 5, 6, 7, 8, 
10, 12, 14, 16, 32 mg/ml. Dilutions of 
ampicillin served as positive control, while 
broth with 20 µl of methanol was used as 
negative control.  
Species 
Local name 
(parts of plant 
used) 
Voucher number Traditional uses 
2-7
 
A. lebbeck  Chhatim (Bark) BSI/CDM/019 Diarrheoa, piles 
T.  chebula  Haritaki (Fruit) BSI/CDM/424 Diarrheoa, indigestion, diabetes 
S. cumini  Jam (Seed) BSI/PKB-SA/03 Diarrheoa, dysentery, piles, indigestion, 
diabetes 
S. nigrum  Kakamachi 
(Fruit) 
BSI/PKB-SA/04 Diarrheoa, inflammation  
P.  kurrooa   Kutki (Rhizomes) BSI/CDM/315 Cholera, diarrheoa, dyspepsia 
B.  monosperma  Palash (Flower) BSI/CDM/063 Diarrhea, piles, inflammation, skin 
disease  
S. indica  Ashok (Flower) BSI/PKB-SA/09 Gastrointestinal disorder 
A.  marmelos   Bel (Leaves) BSI/PKB-SA/10 Cholera, diarrheoa, gastritis, vomiting, 
diabetes  
W. somnifera  Aswagandha 
(root) 
BSI/CDM/458 Diarrhea, dyspepsia, gastrointestinal 
disorder  
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Haemolysis test  
 
Haemolysis test was employed to determine 
cellular toxicity of the extract as previously 
described
12
. Plant extracts at concentrations 
ranging from 6 to 32 mg/ml, were incubated 
with an equal volume of 1% human red blood 
cells in phosphate buffered saline (10mM 
PBS, pH 7.4) at 37°C for 1 h. Non-hemolytic 
and 100% hemolytic controls were the buffer 
alone and the buffer containing 1% Triton X-
100, respectively. Cell lysis was monitored by 
measuring the release of hemoglobin 




Phytochemical screening was performed 
following the method described previously
13
. 
For total phenolics, 0.2 ml of plant extract (5 
mg/ml) was diluted to 3 ml with water and 0.5 
ml of Folin-Ciocalteu reagent was added. 
Following incubation for 3 min at room 
temperature, 2 ml of 20% w/v Na2CO3 was 
added. The mixture was heated in a boiling 
water bath for 1 min and allowed to cool to 
room temperature.  It was centrifuged and the 
content of phenolics in the supernatant was 
determined spectrophotometrically at 650 nm 
(model U-2000, Hitachi), and expressed as 
mg/g of gallic acid equivalents (GAE) per 
lyophylisate. 
 
For total flavonoids, 0.2 ml of dried extract (5 
mg/ml) was diluted to 2 ml with methanol, 
and 0.1 ml of 10% w/v aluminium chloride, 
0.1 ml of 1 mol/lit potassium acetate and 
2.8ml of water were added sequentially. The 
mixture was then incubated at room 
temperature for 30 min. Following 
centrifugation, the flavonoids content of the 
supernatant was measured spectrophoto-
metrically at 415 nm, and expressed as mg/g, 




The results of the tests are presented in 
Tables 2 - 4. The antibiotic susceptibility test 
of the clinical and environmental strains 
included here was performed to confirm their 
multi-drug resistance patterns. These were 
found to conform to multi-drug resistant. 
Antibiotic resistance patterns of V. cholerae, 
strains PC4, PC65, SG24 and NB2 were Fz-
A, A-T, Co-S, and T-Na–Fz-Co-S, 
respectively.  
 
The extracts of T. chebula and S. cumini had 
strong bactericidal activity with MIC ranging 
from 0.125 to 3 mg/ml and MBC ranging from 
0.25 to 4 mg/ml, against V. cholerae 
(serotypes O1, O139, and non-O1, non-
O139) A. hydrophila, and B.  subtilis; and 
moderate activity with MIC, 8-12 mg/ml and 
MBC ranging from 16.0 to 24.0 mg/ml against 
P.  aeruginosa, ETEC and EHEC. S. nigrum 
was active against V. cholerae and did not 
show activity against E. coli and P.  
aeruginosa. The MBC of P. kurrooa extract 
was between 3 and 32 mg/ml against V. 
cholerae and A. hydrophila, but the extract 
was inactive against E. coli and P.  
aeruginosa. The flower extract of B. 
monosperma showed bactericidal activity 
against V. cholerae, A. hydrophila and B.  
subtilis with MBC ranging from 1.75 to 8 
mg/ml. W. somnifera showed strong 
bactericidal activity (MBC, 2 mg/ml) against 
B. subtilis and moderate activity against V. 
cholerae and A. hydrophila with MBC ranging 
from 16 to 32 mg/ml. S. indica evoked strong 
bactericidal activity against V. cholerae and 
A. hydrophila with MBC ranging from 1 to 5 
mg/ml while A. lebbeck and A. marmelos had 
moderate activity against V. cholerae, A. 
hydrophila and B.  subtilis. In addition, the 
bactericidal activity of S. indica against E. coli 
and P. aeruginosa was not observed within 
the concentration ranges of the extracts 
tested.  Except for S. cumini (MIC, 24 mg/ml 
and MBC, 32 mg/ml), all extracts were 
inactive against K. pneumoniae.  
 
Phytochemical screening revealed that the 
crude methanol extracts contained phenolics 
(10.6±0.9 - 365.9±16.1 mg/g) and flavonoids 
(0 - 65.6±2.8 mg/g) (see Table 2). None of 
the extracts tested in the present study 
released haemoglobin and hence were not  
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Table 2: Yield of plant extracts with their phenolic and flavonoid contents  
 










A. lebbeck  5.3 41.9± 0.6 3.0± 1.0 
T.  chebula  47.6 365.9± 16.1 36.3± 1.8 
S. cumini  14.8 231.5±10.3 27.0± 0.9 
S. nigrum  8.0 10.6±0.9 7.3± 0.9 
P.  kurrooa   35.6 56.9± 2.6 6.8± 0.8 
B.  monosperma  27.0 136.5± 5.6 50.2± 2.3 
S. indica  9.3 106.9± 1.2 24.3± 1.9 
A.  marmelos   11.2 68.0± 2.8 65.6± 2.8 
W. somnifera  5.0 11.4±0.5 - 
a
 Total phenolics content is expressed as gallic acid equivalent (mg of GAE/g of extract). 
b
 Total flavonoids are expressed as mg of total flavonoid content/g of extract based on Rutin as standard. 
 
 
Table 3: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of plant 
extracts against multi-drug-resistant strains of V. cholerae serotypes O1, O139, and non-O1, non-O139  
 
Antibacterial activity (mg/ml) 
Strains 

































A.  lebbeck 24.0 24.0 16.0 16.0 16.0 24.0 16.0 16.0 
T.  chebula  1.5 1.5 1.5 1.5 1.5 2.0 0.125 0.25 
S.  cumini  1.5 1.8 1.25 1.25 2.5 3.0 2.0 2.0 
S. nigrum  - - 8.0 12.0 - - - - 
P. kurrooa  12.0 14.0 8.0 16.0 - - 2.0 3.0 
B. monosperma   4.0 4.0 1.75 1.75 5.0 5.0 2.5 2.5 
S. indica   1.5 1.5 3.0 4.0 3.0 4.0 1.0 1.0 
A. marmelos   24.0 24.0 24.0 24.0 24.0 24.0 16.0 16.0 
W. somnifera 16.0 16.0 16.0 16.0 12.0 16.0 8.0 16.0 
Ampicillin 0.016 0.016 0.008 0.008 >1.0 ND ND ND 
-, MIC/MBC was not obtained within the range of concentration (up to 32 mg/ml) of the extract tested; ND, not 
determined. 
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Table 4: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of plant 
extracts against A. hydrophila, E. coli and B. subtilis 
 
-, MIC/MBC was not obtained within the range of concentration (up to 32 mg/ml) of the extract tested; 
ND, not determined. 
cytotoxic to human erythrocytes at 




The extracts of the medicinal plants tested 
were effective antibacterial agents against a 
group of microorganisms that are implicated in 
either cholera, diarrheoa, dysentery or other 
gastrointestinal disorders. All of these plants 
had bactericidal activity against at least one of 
the test microorganisms with MIC ranging 
between 0.125 and 32 mg/ml and MBC 
between 0.25 and 32 mg/ml. Among these, T. 
chebula and S. cumini showed the most 
promising broad spectrum antibacterial 
properties, inhibiting all of the strains tested, 
especially V. cholerae, A. hydrophila and B. 
subtilis, with MBC ranging between 0.25 and 4 
mg/ml. Additionally, the extracts of B. 
monosperma, P. kurrooa, S. indica and S. 
nigrum showed strong bactericidal activity 
against V. cholerae. W. somnifera, B. 
monosperma, A. marmelos and S. indica, and 
were also active against the Gram-positive 
bacterium, B.  subtilis. T. chebula showed 
bactericidal activity against the strain of 
EHEC, the causative agent of hemorrhagic 
colitis, dysentery and haemolytic uraemic 
syndrome (HUS). 
 
It is interesting to note that the extracts of the 
plants used to treat cholera or diarrheoa in 
traditional Medicare systems
2-7
 were effective 
against the strains of V. cholerae, the 
causative agents of the dreadful disease, 
cholera, and cholera-like diseases. To the 
best of our knowledge, the plant extracts used 
in this study are being shown for the first time 
to demonstrate bactericidal activity against 
enterotoxigenic Escherichia coli (ETEC), 
enterohaemorrhagic E. coli (EHEC), A. 
hydrophila, and multi-serogroup strains of V. 
cholerae, the causative agents of different 
Antibacterial activity (mg/ml) 
A. hydrophila PC16 
 
E. coli VT3 
[EHEC] 




































A.  lebbeck 24.0 24.0 - - - - 32.0 - 
T.  chebula  1.0 2.0 12.0 12.0 14.0 16.0 1.0 4.0 
S.  cumini  1.5 1.5 6.0 - 12.0 16.0 2.5 3.0 
S. nigrum  ND ND - - - - ND ND 
P. kurrooa  12 12 - - - - 8.0 - 
B. monosperma   8.0 8.0 - - - - 6.0 8.0 
S. indica   5.0 5.0 - - - - 1.5 - 
A. marmelos   32.0 32.0 - - - - 32.0 32.0 
W. somnifera 32.0 32.0 - - - - 2.0 2.0 
Ampicillin 0.032 0.032 ND ND 1.0 1.0 ND ND 
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enteropathogenic outbreaks and sporadic 
diarrheoa. Phytochemical studies revealed 
that the crude methanol extracts contained 
phenolics and flavonoids and these 
compounds have previously been reported to 




The results of this study give some scientific 
credence to the indigenous uses of the Indian 
medicinal plants evaluated for the treatment 
of gastrointestinal disorders such as cholera 
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